Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2019

26.04.2019 | Review – Clinical Oncology

Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases

verfasst von: Suheil Albert Atallah-Yunes, Anis John Kadado, Gregory P. Kaufman, Jaime Hernandez-Montfort

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The advent of immune checkpoint inhibitors in the treatment of certain types of cancers has revolutionized cancer therapy. In general, these novel agents are more tolerable and have better safety profiles than conventional chemotherapy agents. Although a low incidence of myocarditis was noted as a side effect of immune checkpoint inhibitors in clinical trials, it is being increasingly cited in the literature as their use also increases.

Methods

Using a combination of search terms in the PubMed/Medline database and manual searches on Google Scholar and the bibliographies of articles identified, we reviewed all cases reported in the English language citing myocarditis associated with either pembrolizumab, nivolumab, ipilimumab, or any combination of these agents.

Results

A total of 42 cases were included in the study. Mean age was 65.5 years; 64% were male, 36% were female. One or two doses preceded the onset of myocarditis in 33% and 29% of cases, respectively. Steroids were used as the first-line therapy in 90% of cases. Complete heart block occurred in 36% of cases. Fourteen (33%) deaths were reported, with 64% and 29% of deaths occurring after one or two doses, respectively.

Conclusion

Most cases and fatalities of myocarditis occurred shortly after initiation of immune checkpoint inhibitor therapy. Arrhythmias, particularly complete heart block, appear to be related to the occurrence of more severe and fatal cases. The use of serial electrocardiograms or biomarkers of myocardial injury may be crucial in detecting early stages of the disease process. Further research establishing more specific guidelines is necessary in dealing with this potentially fatal side effect.
Literatur
Zurück zum Zitat Cooper LT et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50:1914–1931. https://doi.org/10.1016/j.jacc.2007.09.008 CrossRefPubMed Cooper LT et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 50:1914–1931. https://​doi.​org/​10.​1016/​j.​jacc.​2007.​09.​008 CrossRefPubMed
Zurück zum Zitat Copeland-Halperin R, Sahni GD (2018) Autoimmune Myocarditis With AV Block: Too Much of a Good Thing? JACC Copeland-Halperin R, Sahni GD (2018) Autoimmune Myocarditis With AV Block: Too Much of a Good Thing? JACC
Zurück zum Zitat Cristina AADLA, Escudier-Villa JM, Ortega Marcos J, Silva-Melchor L (2017) Progressive exertional dyspnea and fatigue in an oncology-patient. Austin J Clin Cardiolog 4(2):1058 Cristina AADLA, Escudier-Villa JM, Ortega Marcos J, Silva-Melchor L (2017) Progressive exertional dyspnea and fatigue in an oncology-patient. Austin J Clin Cardiolog 4(2):1058
Zurück zum Zitat Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232CrossRefPubMed Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232CrossRefPubMed
Zurück zum Zitat Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64:1235–1245CrossRefPubMed Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64:1235–1245CrossRefPubMed
Zurück zum Zitat Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, Schultheiss HP (1997) Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 30:1354–1359CrossRefPubMed Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, Schultheiss HP (1997) Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 30:1354–1359CrossRefPubMed
Zurück zum Zitat Nieminen MS, Heikkila J, Karjalainen J (1984) Echocardiography in acute infectious myocarditis: relation to clinical and electrocardiographic findings. Am J Cardiol 53:1331–1337CrossRefPubMed Nieminen MS, Heikkila J, Karjalainen J (1984) Echocardiography in acute infectious myocarditis: relation to clinical and electrocardiographic findings. Am J Cardiol 53:1331–1337CrossRefPubMed
Metadaten
Titel
Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases
verfasst von
Suheil Albert Atallah-Yunes
Anis John Kadado
Gregory P. Kaufman
Jaime Hernandez-Montfort
Publikationsdatum
26.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2019
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-02927-x

Weitere Artikel der Ausgabe 6/2019

Journal of Cancer Research and Clinical Oncology 6/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.